Global Epigenetics Market 2024-2028

Description

List of Tables

The epigenetics market is forecasted to grow by USD 1477.78 mn during 2023-2028, accelerating at a CAGR of 14.75% during the forecast period. The report on the epigenetics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising epigenetic applications in non-oncology diseases, increasing prevalence of CVDs, and rising strategic collaboration among vendors.

Technavio's epigenetics market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	13.54%
CAGR	14.75%
Incremental Value	$1477.78mn

By Application

Oncology
Non-oncology

By Product

Reagents
Kits
Enzymes and others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advances in the life sciences industry as one of the prime reasons driving the epigenetics market growth during the next few years. Also, the rising number of genome projects and the increasing number of recent developments in epigenetics will lead to sizable demand in the market.

The report on the epigenetics market covers the following areas:

Epigenetics market sizing
Epigenetics market forecast
Epigenetics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epigenetics market vendors that include Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Eisai Co. Ltd., Element Biosciences Inc, EpiGentek Group Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Novartis AG, Pacific Biosciences of California Inc., PerkinElmer Inc, Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Zymo Research Corp., and CellCentric Ltd.. Also, the epigenetics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75055

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global epigenetics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global epigenetics market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2023-2028
Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
6.4 Non-oncology - Market size and forecast 2023-2028
Exhibit 38: Chart on Non-oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Non-oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Non-oncology - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Non-oncology - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Reagents - Market size and forecast 2023-2028
Exhibit 48: Chart on Reagents - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Reagents - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Reagents - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Reagents - Year-over-year growth 2023-2028 (%)
7.4 Kits - Market size and forecast 2023-2028
Exhibit 52: Chart on Kits - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Kits - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Kits - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Kits - Year-over-year growth 2023-2028 (%)
7.5 Enzymes and others - Market size and forecast 2023-2028
Exhibit 56: Chart on Enzymes and others - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Enzymes and others - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Enzymes and others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Enzymes and others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abcam plc
Exhibit 111: Abcam plc - Overview
Exhibit 112: Abcam plc - Product / Service
Exhibit 113: Abcam plc - Key news
Exhibit 114: Abcam plc - Key offerings
12.4 Active Motif Inc.
Exhibit 115: Active Motif Inc. - Overview
Exhibit 116: Active Motif Inc. - Product / Service
Exhibit 117: Active Motif Inc. - Key offerings
12.5 Agilent Technologies Inc.
Exhibit 118: Agilent Technologies Inc. - Overview
Exhibit 119: Agilent Technologies Inc. - Business segments
Exhibit 120: Agilent Technologies Inc. - Key offerings
Exhibit 121: Agilent Technologies Inc. - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 122: Bio Rad Laboratories Inc. - Overview
Exhibit 123: Bio Rad Laboratories Inc. - Business segments
Exhibit 124: Bio Rad Laboratories Inc. - Key news
Exhibit 125: Bio Rad Laboratories Inc. - Key offerings
Exhibit 126: Bio Rad Laboratories Inc. - Segment focus
12.7 Eisai Co. Ltd.
Exhibit 127: Eisai Co. Ltd. - Overview
Exhibit 128: Eisai Co. Ltd. - Business segments
Exhibit 129: Eisai Co. Ltd. - Key offerings
Exhibit 130: Eisai Co. Ltd. - Segment focus
12.8 EpiGentek Group Inc.
Exhibit 131: EpiGentek Group Inc. - Overview
Exhibit 132: EpiGentek Group Inc. - Product / Service
Exhibit 133: EpiGentek Group Inc. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Illumina Inc.
Exhibit 139: Illumina Inc. - Overview
Exhibit 140: Illumina Inc. - Business segments
Exhibit 141: Illumina Inc. - Key news
Exhibit 142: Illumina Inc. - Key offerings
Exhibit 143: Illumina Inc. - Segment focus
12.11 Merck KGaA
Exhibit 144: Merck KGaA - Overview
Exhibit 145: Merck KGaA - Business segments
Exhibit 146: Merck KGaA - Key news
Exhibit 147: Merck KGaA - Key offerings
Exhibit 148: Merck KGaA - Segment focus
12.12 New England Biolabs Inc.
Exhibit 149: New England Biolabs Inc. - Overview
Exhibit 150: New England Biolabs Inc. - Product / Service
Exhibit 151: New England Biolabs Inc. - Key news
Exhibit 152: New England Biolabs Inc. - Key offerings
12.13 Pacific Biosciences of California Inc.
Exhibit 153: Pacific Biosciences of California Inc. - Overview
Exhibit 154: Pacific Biosciences of California Inc. - Product / Service
Exhibit 155: Pacific Biosciences of California Inc. - Key offerings
12.14 PerkinElmer Inc
Exhibit 156: PerkinElmer Inc - Overview
Exhibit 157: PerkinElmer Inc - Business segments
Exhibit 158: PerkinElmer Inc - Key news
Exhibit 159: PerkinElmer Inc - Key offerings
Exhibit 160: PerkinElmer Inc - Segment focus
12.15 QIAGEN NV
Exhibit 161: QIAGEN NV - Overview
Exhibit 162: QIAGEN NV - Product / Service
Exhibit 163: QIAGEN NV - Key news
Exhibit 164: QIAGEN NV - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 165: Thermo Fisher Scientific Inc. - Overview
Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
Exhibit 167: Thermo Fisher Scientific Inc. - Key news
Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
12.17 Zymo Research Corp.
Exhibit 170: Zymo Research Corp. - Overview
Exhibit 171: Zymo Research Corp. - Product / Service
Exhibit 172: Zymo Research Corp. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations